Samit Hirawat
Patrimonio netto: 2 M $ in data 31/08/2026
Patrimonio netto: 2 M $ in data 31/08/2026
Dr. Samit Hirawat, MD, is an Independent Director at Pacira Biosciences, Inc. and an Operating Partner at Jeito Capital /US/.
He is on the Board of Directors at Pacira Biosciences, Inc. Dr. Hirawat was previously employed as a Chief Medical Officer, EVP & Head-Development by Bristol Myers Squibb Co. and a Head- Global Oncology Development by Novartis AG.
He received his undergraduate degree from SMS Medical College & Hospital.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 12/03/2026 | 31.925 ( 0% ) | 2 M $ | 31/08/2026 | |
| 10/06/2026 | 6.405 ( 0,02% ) | 165 890 $ | 31/08/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| PACIRA BIOSCIENCES, INC. | Direttore/Membro del Consiglio | 27/01/2026 |
Entos, Inc.
Entos, Inc. Packaged SoftwareTechnology Services Develops AI driven platform for drug discovery | Direttore/Membro del Consiglio | 01/08/2026 |
| Società | Posizione | Fine |
|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Direttore Tecnico/Scientifico/R&S | 01/08/2025 |
| NOVARTIS AG | Corporate Officer/Principal | 01/06/2019 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 5 |
|---|---|
Bristol Myers Squibb Co.
Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Novartis AG
Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
Pacira Biosciences, Inc.
Pacira Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures injectable therapeutic products | Health Technology |
SMS Medical College & Hospital
SMS Medical College & Hospital Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Entos, Inc.
Entos, Inc. Packaged SoftwareTechnology Services Develops AI driven platform for drug discovery | Technology Services |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale